View the LUCIGEFI 250 MG registration information details.
Back to drug list
ItemsDrug Registration information
ID1736
No1736
Brand NameLUCIGEFI 250 MG
IngredientsGEFITINIB 250 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 30'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE FIRST LINE TREATMENT OF PATIENTS WITH METASTATIC NON SMALL CELL LUNG CANCER WHOSE TUMORS HAVE EPIDERMAL GROWTH FACTOR RECEPTOR EXON 19 DELETIONS OR EXON 21
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionBROWNISH ROUNF TABLET
Note
License OwnerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
ManufacturerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No09 L 1215/24
FDD Registration Date31/10/2024
Expiry Date30/10/2029
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA